5, 9 May 2025, pp 450-65,
The standard dosing schedule is what ships with your medication, and getting individualized adjustments is difficult given the limited access to providers through the platform
They occur in 1 out of 5 women by age 60, and they are half as common in men
Based on the typical UK regulatory pathway, the most realistic timeline is: Late 2026 / early 2027: Eli Lilly expected to submit regulatory filings to the FDA and MHRA following completion of the remaining TRIUMPH Phase 3 readouts Late 2027 to mid-2028: Possible MHRA marketing authorisation, allowing private UK prescribing 2028 to 2029 onwards: Possible NHS availability following a NICE technology appraisal and NHS commissioning decisions Timelines may differ across the four UK nations, as Scotland, Wales, and Northern Ireland assess medicines separately through the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), and the Department of Health Northern Ireland respectively
Based on the available data, the peptide is well tolerated in short-term studies
A daily pill would be easier to use and, because it would be cheaper to manufacture, could possibly lower patient costs, expert say
